Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo dendritic cell reprogramming for cancer immunotherapy
Ervin Ascic, Fritiof Åkerström, M. Nair, et al.
Science (2024) Vol. 386, Iss. 6719
Open Access | Times Cited: 20

Showing 20 citing articles:

Cross-priming in cancer immunology and immunotherapy
Carlos Luri‐Rey, Álvaro Teijeira, Stefanie K. Wculek, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 3
Cancer cell reprogramming: turning the enemy into an ally
Severin Guetter, Kaiji Fan, Hendrik Poeck
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Cryo‐Shocked Tumor‐Reprogrammed Sonosensitive Antigen‐Presenting Cells Improving Sonoimmunotherapy via T Cells and NK Cells Immunity
Xindi Qian, Wenzhe Yi, Wenlu Yan, et al.
Advanced Materials (2025)
Closed Access
Topology‐Oriented Lymph Node Drainage of Dendritic Polymer‐TLR Agonist Conjugates to Enhance Vaccine Immunogenicity
Long Ren, Bing Wang, Di Miao, et al.
Advanced Materials (2025)
Closed Access
Dendritic cell immunotherapy has its antitumor action improved by the LPS in the maturation process
Angela Maria Moed Lopes, Jéssica Ferreira Vieira, Saulo Fernando Moreira da Silva, et al.
Clinical & Translational Oncology (2025)
Closed Access
Modulation of the tumor immune microenvironment by Interferon Regulatory Factor 8 enhances immunotherapy in lung adenocarcinoma
Wen Huo, Minxin Chen, Cheng Chang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit
Kristen E. Pauken, Omar Alhalabi, Sangeeta Goswami, et al.
Cancer Cell (2025)
Closed Access
Cell reprogramming: methods, mechanisms and applications
Fei Zhu, Guangjun Nie
Cell Regeneration (2025) Vol. 14, Iss. 1
Open Access
CD8+ T Cell Subsets as Biomarkers for Predicting Checkpoint Therapy Outcomes in Cancer Immunotherapy
Rosaely Casalegno‐Garduño, Alf Spitschak, Tim Pannek, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 930-930
Open Access
A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming
Mina Afrashteh Nour, Mansour Rajabivahid, Marjan Sadat Seyed Mehdi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Dendritic cells instruct T cell anti-tumor immunity and immunotherapy response
Zhen Xiao, Jiajia Wang, Jingxing Yang, et al.
The Innovation Medicine (2025), pp. 100128-100128
Closed Access
Advances in cell therapy: progress and challenges in hematological and solid tumors
Claudia D'Avanzo, Franziska Blaeschke, Memnon Lysandrou, et al.
Trends in Pharmacological Sciences (2024)
Open Access | Times Cited: 3
MCRS1 sensitizes T cell–dependent immunotherapy by augmenting MHC-I expression in solid tumors
Xue Li, Yi Han, Zheyu Jin, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 12
Closed Access | Times Cited: 1
Tumour cells get a dendritic cell makeover
M. Teresa Villanueva
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 11, pp. 814-814
Closed Access
A New Frontier in Tumor Eradication: Harnessing In Vivo Cellular Reprogramming for Durable Cancer Immunotherapy
Constantinos Chronis
Cellular Reprogramming (2024) Vol. 26, Iss. 5, pp. 132-134
Closed Access
Reprogramming tumor cells to fight cancer
Haibo Zhou, Li Wu
Science (2024) Vol. 386, Iss. 6719, pp. 274-275
Closed Access
Antigen-specific T cell immunotherapy by in vivo mRNA delivery
Fang‐Yi Su, Jamison C. Siebart, Ching Shen Chan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enhancing tumor immunity via in vivo cDC1 reprogramming
Yoojung Kwon, Kyunghee Choi
Trends in Immunology (2024)
Open Access
Transcription factor–mediated reprogramming to antigen-presenting cells
Ervin Ascic, Carlos‐Filipe Pereira
Current Opinion in Genetics & Development (2024) Vol. 90, pp. 102300-102300
Open Access
Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage–T Cell Interaction for Intratumoral T Cell Motility
Benedikt Slusny, Vincent Zimmer, Elena Nasiri, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 51-51
Open Access
Page 1

Scroll to top